Aladdin Biotech Overview
- Year Founded
-
2009
- Status
-
Public
- Employees
-
926
- Stock Symbol
-
688179
- Investments
-
4
- Share Price
-
$1.86
- (As of Friday Closing)
Aladdin Biotech General Information
Description
Shanghai Aladdin Biochemical Technology Co Ltd is engaged in research and development, production and sales of scientific reagents in the fields of chemistry, life sciences and materials science. Its products are widely used in the field of basic sciences.
Contact Information
Website
www.aladdin-e.comCorporate Office
- 6th Floor, Shanda Building
- No.196 Xinjinqiao Road, Pudong New Area
- Shanghai
- China
Corporate Office
- 6th Floor, Shanda Building
- No.196 Xinjinqiao Road, Pudong New Area
- Shanghai
- China
Aladdin Biotech Stock Performance
As of 20-Nov-2026, Aladdin Biotech’s stock price is $1.86. Its current market cap is $674M with 363M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.86 | $2.00 | $1.74 - $4.66 | $674M | 363M | 14M | $0.06 |
Aladdin Biotech Financials Summary
As of 30-Sep-2026, Aladdin Biotech has a trailing 12-month revenue of $120M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,212,765 | 609,065 | 519,060 | 507,382 |
| Revenue | 120,257 | 96,745 | 74,358 | 56,945 |
| EBITDA | 29,262 | 29,518 | 23,293 | 17,447 |
| Net Income | 20,712 | 14,192 | 13,764 | 12,132 |
| Total Assets | 404,549 | 379,632 | 243,616 | 212,391 |
| Total Debt | 62,612 | 110,210 | 60,335 | 50,258 |
Aladdin Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Aladdin Biotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Aladdin Biotech Signals
Aladdin Biotech Investments & Acquisitions (4)
Aladdin Biotech’s most recent deal was a Corporate with Yazyme Biotech for . The deal was made on 25-Jul-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Yazyme Biotech | 25-Jul-2025 | Corporate | Discovery Tools (Healthcare) | ||
| Neolab Migge | 07-Jul-2025 | Later Stage VC | Laboratory Services (Healthcare) | ||
| CASMART | 04-Jul-2025 | Merger/Acquisition | Other Commercial Services | ||
| Yuanye | 17-Apr-2024 | Merger/Acquisition | Biotechnology |
Aladdin Biotech ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Aladdin Biotech Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| CASMART | Beijing, China | 2016 | |
| Yuanye | Shanghai, China | 2009 |
Aladdin Biotech FAQs
-
When was Aladdin Biotech founded?
Aladdin Biotech was founded in 2009.
-
Where is Aladdin Biotech headquartered?
Aladdin Biotech is headquartered in Shanghai, China.
-
What is the size of Aladdin Biotech?
Aladdin Biotech has 926 total employees.
-
What industry is Aladdin Biotech in?
Aladdin Biotech’s primary industry is Specialty Chemicals.
-
Is Aladdin Biotech a private or public company?
Aladdin Biotech is a Public company.
-
What is Aladdin Biotech’s stock symbol?
The ticker symbol for Aladdin Biotech is 688179.
-
What is the current stock price of Aladdin Biotech?
As of 20-Nov-2026 the stock price of Aladdin Biotech is $1.86.
-
What is the current market cap of Aladdin Biotech?
The current market capitalization of Aladdin Biotech is $674M.
-
What is Aladdin Biotech’s current revenue?
The trailing twelve month revenue for Aladdin Biotech is $120M.
-
What is Aladdin Biotech’s annual earnings per share (EPS)?
Aladdin Biotech’s EPS for 12 months was $0.06.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process